
Join All of Us and Help Make Medicine...
The All of Us research program, sponsored by the National Institutes of Health (NIH), is an ambitious, nationwide effort to find better...
This study is designed to investigate the safety and efficacy of Nab®-Paclitaxel (ABRAXANE®) in combination with Carboplatin as first line treatment.
Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.
For more information about this study:
https://clinicaltrials.gov/ct2/show/NCT02151149